{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:03:35Z","timestamp":1777950215816,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04645-0","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:34:53Z","timestamp":1777876493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemoglobin glycation index and renal progression in patients with type 2 diabetes: a 5-year cohort study"],"prefix":"10.1007","volume":"91","author":[{"given":"Chin-Sung","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Rong","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Shun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"5","key":"4645_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s1056-8727(01)00227-6","volume":"16","author":"JM Hempe","year":"2002","unstructured":"J.M. Hempe, R. Gomez, R.J. Jr. McCarter, S.A. Chalew, High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J. Diabetes Complications. 16(5), 313\u2013320 (2002). https:\/\/doi.org\/10.1016\/s1056-8727(01)00227-6","journal-title":"J. Diabetes Complications"},{"issue":"6","key":"4645_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2337\/dc14-1844","volume":"38","author":"JM Hempe","year":"2015","unstructured":"J.M. Hempe, S. Liu, L. Myers, R.J. McCarter, J.B. Buse, V. Fonseca, The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 38(6), 1067\u20131074 (2015). https:\/\/doi.org\/10.2337\/dc14-1844","journal-title":"Diabetes Care"},{"issue":"4","key":"4645_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00125-017-4539-1","volume":"61","author":"SC van Steen","year":"2018","unstructured":"van S.C. Steen, M. Woodward, J. Chalmers et al., Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 61(4), 780\u2013789 (2018). https:\/\/doi.org\/10.1007\/s00125-017-4539-1","journal-title":"Diabetologia"},{"issue":"8","key":"4645_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/2047487317692664","volume":"24","author":"SC van Steen","year":"2017","unstructured":"van S.C. Steen, I.C. Schrieks, J.B. Hoekstra et al., The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial. Eur. J. Prev. Cardiol. 24(8), 858\u2013866 (2017). https:\/\/doi.org\/10.1177\/2047487317692664","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"4645_CR5","doi-asserted-by":"publisher","first-page":"19629","DOI":"10.1038\/s41598-024-70666-2","volume":"14","author":"Y Huang","year":"2024","unstructured":"Y. Huang, X. Huang, L. Zhong, J. Yang, Glycated haemoglobin index is a new predictor for all-cause mortality and cardiovascular mortality in the adults. Sci. Rep. 14(1), 19629 (2024). https:\/\/doi.org\/10.1038\/s41598-024-70666-2","journal-title":"Sci. Rep."},{"key":"4645_CR6","doi-asserted-by":"publisher","first-page":"1108061","DOI":"10.3389\/fendo.2023.1108061","volume":"14","author":"S Xin","year":"2023","unstructured":"S. Xin, X. Zhao, J. Ding, X. Zhang, Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: A cross- sectional inpatient study. Front. Endocrinol. (Lausanne). 14, 1108061 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1108061","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4645_CR7","doi-asserted-by":"publisher","first-page":"109834","DOI":"10.1016\/j.diabres.2022.109834","volume":"186","author":"CH Lin","year":"2022","unstructured":"C.H. Lin, Y.C. Lai, T.J. Chang, Y.D. Jiang, Y.C. Chang, L.M. Chuang, Hemoglobin glycation index predicts renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease. Diabetes Res. Clin. Pract. 186, 109834 (2022). https:\/\/doi.org\/10.1016\/j.diabres.2022.109834","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4645_CR8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/DMSO.S523442","volume":"18","author":"W Zhou","year":"2025","unstructured":"W. Zhou, L. Zhang, T. Liu, Association Between the Hemoglobin Glycation Index (HGI) and Risk of Diabetic Nephropathy: A Retrospective Cohort Study. Diabetes Metab. Syndr. Obes. 18, 1859\u20131872 (2025). https:\/\/doi.org\/10.2147\/DMSO.S523442","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"5","key":"4645_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3803\/EnM.2024.2001","volume":"39","author":"CRL Cardoso","year":"2024","unstructured":"C.R.L. Cardoso, N.C. Leite, G.F. Salles, Importance of the Hemoglobin Glycation Index for Risk of Cardiovascular and Microvascular Complications and Mortality in Individuals with Type 2 Diabetes. Endocrinol. Metab. (Seoul). 39(5), 732\u2013747 (2024). https:\/\/doi.org\/10.3803\/EnM.2024.2001","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"9","key":"4645_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"A.S. Levey, L.A. Stevens, C.H. Schmid et al., A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604\u2013612 (2009). https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"4645_CR11","doi-asserted-by":"publisher","first-page":"20683","DOI":"10.1038\/s41598-020-77804-6","volume":"10","author":"RH Chou","year":"2020","unstructured":"R.H. Chou, S.S. Huang, C.S. Kuo et al., Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography. Sci. Rep. 10(1), 20683 (2020). https:\/\/doi.org\/10.1038\/s41598-020-77804-6","journal-title":"Sci. Rep."},{"issue":"1","key":"4645_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41598-020-58132-1","volume":"10","author":"CS Kuo","year":"2020","unstructured":"C.S. Kuo, R.H. Chou, Y.W. Lu, Y.L. Tsai, P.H. Huang, S.J. Lin, Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography. Sci. Rep. 10(1), 1435 (2020). https:\/\/doi.org\/10.1038\/s41598-020-58132-1","journal-title":"Sci. Rep."},{"issue":"1","key":"4645_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2337\/db13-0782","volume":"63","author":"DM Nathan","year":"2014","unstructured":"D.M. Nathan, P. McGee, M.W. Steffes, J.M. Lachin, D.E.R. Group, Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT\/EDIC study. Diabetes. 63(1), 282\u2013290 (2014). https:\/\/doi.org\/10.2337\/db13-0782","journal-title":"Diabetes"},{"key":"4645_CR14","doi-asserted-by":"publisher","unstructured":"R.S. Pinto, C.A. Minanni, de A.L. Araujo Lira, M. Passarelli, Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. Int. J. Mol. Sci. 23(5) (2022). https:\/\/doi.org\/10.3390\/ijms23052404","DOI":"10.3390\/ijms23052404"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04645-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:34:54Z","timestamp":1777876494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4645"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04645-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Taipei Veterans General Hospital (2015-12-011BC) and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants signed informed consent for the publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"175"}}